Correlation Between PTC Therapeutics and MAIA Biotechnology
Can any of the company-specific risk be diversified away by investing in both PTC Therapeutics and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PTC Therapeutics and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PTC Therapeutics and MAIA Biotechnology, you can compare the effects of market volatilities on PTC Therapeutics and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PTC Therapeutics with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of PTC Therapeutics and MAIA Biotechnology.
Diversification Opportunities for PTC Therapeutics and MAIA Biotechnology
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between PTC and MAIA is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding PTC Therapeutics and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and PTC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PTC Therapeutics are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of PTC Therapeutics i.e., PTC Therapeutics and MAIA Biotechnology go up and down completely randomly.
Pair Corralation between PTC Therapeutics and MAIA Biotechnology
Given the investment horizon of 90 days PTC Therapeutics is expected to generate 0.37 times more return on investment than MAIA Biotechnology. However, PTC Therapeutics is 2.7 times less risky than MAIA Biotechnology. It trades about -0.03 of its potential returns per unit of risk. MAIA Biotechnology is currently generating about -0.13 per unit of risk. If you would invest 4,654 in PTC Therapeutics on November 4, 2024 and sell it today you would lose (66.00) from holding PTC Therapeutics or give up 1.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
PTC Therapeutics vs. MAIA Biotechnology
Performance |
| Timeline |
| PTC Therapeutics |
| MAIA Biotechnology |
PTC Therapeutics and MAIA Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PTC Therapeutics and MAIA Biotechnology
The main advantage of trading using opposite PTC Therapeutics and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PTC Therapeutics position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.| PTC Therapeutics vs. Krystal Biotech | PTC Therapeutics vs. Sarepta Therapeutics | PTC Therapeutics vs. Iovance Biotherapeutics | PTC Therapeutics vs. Madrigal Pharmaceuticals |
| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |